关于使用连续集成和连续交付的物联网设备的安全和自动无线固件更新机制的建议
Noprianto1, Nobuo Funabiki1, Htoo Htoo Sandi Kyaw1
1Department of Information and Communication Systems, Okayama University, Okayama 700-8530, Japan.
Sensors (Basel, Switzerland)
|March 14, 2026
概括
本研究介绍了用于物联网 (IoT) 的自动无线 (OTA) 固件更新机制. 该系统集成了持续集成和交付,以实现安全,高效和可靠的固件管理,解决常见的更新挑战.
科学领域:
- 计算机科学 计算机科学
- 电气工程 电气工程
- 网络安全 网络安全
背景情况:
- 物联网 (IoT) 设备的扩散需要强大的固件管理解决方案.
- 现有的固件更新流程面临挑战,包括版本回滚,未经授权的修改和中间人 (MITM) 攻击.
- 安全和自动的无线 (OTA) 固件更新机制对于保持物联网生态系统完整性至关重要.
研究的目的:
- 为物联网设备提出一个自动化的OTA固件更新机制.
- 通过与连续集成 (CI) 和连续交付 (CD) 管道的集成来增强固件更新安全性,可靠性和效率.
- 确保可信的固件来源,并提供错误处理和监控功能.
主要方法:
- 开发了一个自动化的OTA固件更新机制.
- 将该机制与CI/CD管道集成,用于可信的固件部署.
- 使用SEMAR物联网应用服务器实施和评估该提案.
- 进行完整性,身份验证,性能,资源利用和基准测试的测试.
主要成果:
- 拟议的机制成功验证了固件完整性和认证.
- 测量了性能和资源利用,证明了效率.
- 基准测试证实了自动更新过程的可靠性和效率.
- 该系统有效地解决了安全问题,如MITM攻击和修改的固件文件.
结论:
- 拟议的自动化OTA固件更新机制可靠且有效地管理物联网设备.
- 与CI/CD集成可确保可信的固件源,并提高整体安全性.
- 该解决方案为安全和可管理的物联网固件部署提供了强大的框架.
相关概念视频
01:25Distribution Reliability and Automation
557
Distribution reliability in electrical power systems is critical for ensuring an uninterrupted power supply to consumers at minimal cost. According to IEEE Standard Terms, reliability is the probability that a device will function without failure over a specified time period or amount of usage. For electric power distribution, this translates to maintaining continuous power supply and addressing customer concerns over power outages. Several indices, as defined by IEEE Standard 1366-2012, are...
557
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
76
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
76
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72
01:19Modified-Release Drug Delivery Systems: Overview
97
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
97
01:19Quality Assurance
3.8K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
3.8K
01:23Modified-Release Drug Delivery Systems: Classification
167
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
167